Irvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today announced the introduction of Arctic™ Sperm Cryopreservation Medium. This new medium is formulated to improve the post-thaw performance of frozen sperm samples and reduce the cost of sperm cryopreservation.
Increasing numbers of infertility cases are found to be caused by male reproductive problems. Overcoming these is an important factor for successful in vitro fertilization. Sperm cryopreservation is often performed as insurance in case a fresh sample fails, for poor quality semen, and to preserve samples for sperm donation. Arctic Sperm Cryopreservation Medium has an enriched formula high in glycerol that provides effective cryopreservation at a low 3:1 ratio of semen to medium. This minimizes dilution of poor quality samples compared to most commercial sperm cryopreservation media that require a 1:1 ratio. Arctic Sperm Cryopreservation Medium uses a dual buffer system of HEPES and MOPS that maintains a stable environment while on the benchtop. These benefits result in the improved post-thaw performance of sperm.
Andrology and IVF laboratories need to keep the cost of sperm cryopreservation and storage down. Arctic Sperm Cryopreservation Medium requires 60% less medium per application—resulting in significant savings. It also increases the amount of semen stored per cryovial or straw to aid in reducing storage costs.
“We applied the latest knowledge of media formulation to develop a medium that provides the stability required to minimize stress on the specimen during processing,” said Dr. Jessie Ni, Chief Scientific Officer at Irvine Scientific. “Irvine Scientific has been at the forefront of developing products for andrology since 1987, and Arctic Sperm Cryopreservation Medium represents our continued commitment to improving success in the andrology laboratory.”
Arctic Sperm Cryopreservation Medium does not contain test yolk buffer (TYB) and is available in kits of 12 x 5 mL.
For more information visit http://www.irvinesci.com/assisted-reproductive-technology
About Irvine Scientific
Irvine Scientific, a member of JXTG Group, is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivalled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 45 years, Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.
Media contacts
Lori Serles, Irvine Scientific
Phone: 949-261-7800 x145
Email: lserles@irvinesci.com
Lorna Cuddon, Zyme Communications
Phone: +44 (0)7811996942
Email: lorna.cuddon@zymecommunications.com
